IVW iShares S&P 500 Growth ETF

Expense Ratio
0.18%
Dividend
0.43%
Previous close
$114.66
Est. 12 months change
+29.21%
Projected Price
$148.16

Profitability Metrics

Return on Equity (ROE)
55.95%
Return on Assets (ROA)
18.79%
Return on Invested Capital (ROIC)
49.27%
Weighted Average Cost of Capital (WACC)
11.12%
ROIC - WACC
38.15%
Updated : 2026-04-04 06:58 ET

Valuation Metrics

P/E Ratio
31.25
Forward P/E
22.45
PEG Ratio
1.63
Debt Current Ratio
2.08

Growth & Cash Flow

Gross Margin
61.46%
Operating Margin
36.31%
FCF Margin
26.70%
TTM Revenue Growth
29.45%
Projected 12M EPS Growth
39.19%

Price Change

Price % from 50 SMA
-3.76%
Price % from 200 SMA
-3.34%
6 Months
-5.55%
1 Year
21.58%
2 Years
36.48%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
NVDA14.96%
MSFT9.74%
AAPL6.71%
GOOGL5.88%
AVGO5.25%
GOOG4.71%
META4.22%
AMZN3.79%
LLY2.56%
TSLA2.32%

ETF Analysis

Fund Overview

iShares S&P 500 Growth ETF (IVW) currently reports 142 stock positions (subject to change), placing it in the broad-based range by holdings breadth. The top line-up is NVDA (14.96%), MSFT (9.74%), AAPL (6.71%), with NVDA as the largest single weight at 14.96%. Together, the top three holdings account for 31.41%, which suggests investors should pay close attention to the largest holdings, as they carry outsized influence on aggregate returns. The overall construction balances concentrated exposure at the top with broader diversification through the rest of the book.

Profitability & Capital Efficiency

Through the lens of capital efficiency, ROIC is 49.27%, WACC is 11.12%, and the economic spread is 38.15%. On balance, reinvested capital is working exceptionally hard, with operating returns clearing the funding cost hurdle by a wide margin. Supporting metrics show ROE at 55.95% and ROA at 18.79%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

Assessed on a multiple basis, trailing P/E of 31.25, forward P/E of 22.45, PEG of 1.63. Forward P/E comes in somewhat below trailing — a gap that is supportive of the valuation case without implying a sharp near-term earnings inflection. Growth-adjusted, the multiple is in an acceptable range — the portfolio is neither pricing in perfection nor offering a meaningful valuation discount. The portfolio's weighted current ratio of 2.08 reflects adequate near-term financial stability. Overall, the valuation setup reads as a balance between expected growth and execution risk, with liquidity acting as an important stabilizer if macro conditions become less favorable.

Margins & Cash Generation

The margin profile breaks down as follows: gross margin sits at 61.46%, operating margin at 36.31%, and free cash flow margin at 26.70%. The portfolio's gross margin reflects businesses that retain a large share of revenue before overhead — a sign of genuine competitive insulation. Operating margins are exceptional, indicating management teams that scale revenues while keeping costs tightly controlled. FCF margins at this level reflect businesses that fund growth entirely from internal resources, with significant cash left over. The full margin profile here is impressive — pricing power, operating leverage, and cash conversion are all working in the same direction.

Growth & Forward Outlook

The growth and outlook picture reads as follows: TTM revenue growth of 29.45% pointing to healthy demand conditions for the businesses represented in the fund. In parallel, analysts project moderate appreciation over the next 12 months based on current consensus targets. The gap between trailing fundamentals and forward expectations matters most at inflection points — and the current environment is not without those. For long-term holders, the central question is whether today's execution quality is a leading indicator of what's already priced into analyst targets. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Strong Buy

Reviewed in aggregate, this is a high-quality profile with few clear structural weaknesses — a combination that historically tends to support above-average long-term outcomes.

These findings are based solely on the metrics presented and do not constitute an investment recommendation. Always perform your own due diligence before committing capital.